Burgers J K, Hinkle G H, Haseman M K
Urology Surgeons Inc, Riverside Hospital, Columbus, OH 43214-3901, USA.
Semin Urol. 1995 May;13(2):103-12.
In summary, this agent is safe for administration and more accurate than any currently available imaging modality for the detection of extraprostatic metastases. This agent is still under investigation and some day may aid urologists in the evaluation of prostate cancer by improving preoperative staging and demonstration of advanced disease and postoperative localization of recurrent disease. Improved staging and localization will reduce unnecessary tests and treatment that will lead to reduced morbidity, better management, earlier detection, and intervention in advanced disease and improved cost-effectiveness.
总之，这种制剂给药安全，在检测前列腺外转移方面比任何现有成像方式都更准确。该制剂仍在研究中，未来某天可能会通过改善术前分期、显示晚期疾病以及术后复发病灶的定位，帮助泌尿科医生评估前列腺癌。改进分期和定位将减少不必要的检查和治疗，从而降低发病率、改善治疗管理、更早发现和干预晚期疾病，并提高成本效益。
